Varex/$VREX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Varex
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.
Ticker
$VREX
Sector
Primary listing
Employees
2,300
Headquarters
Website
Varex Metrics
BasicAdvanced
$499M
-
-$3.22
0.68
-
Price and volume
Market cap
$499M
Beta
0.68
52-week high
$16.47
52-week low
$6.76
Average daily volume
224K
Financial strength
Current ratio
3.506
Quick ratio
1.639
Long term debt to equity
83.301
Total debt to equity
84.537
Interest coverage (TTM)
-1.04%
Profitability
EBITDA (TTM)
-9.4
Gross margin (TTM)
34.06%
Net profit margin (TTM)
-16.13%
Operating margin (TTM)
-4.44%
Effective tax rate (TTM)
-86.44%
Revenue per employee (TTM)
$360,000
Management effectiveness
Return on assets (TTM)
-1.96%
Return on equity (TTM)
-24.79%
Valuation
Price to revenue (TTM)
0.604
Price to book
1.1
Price to tangible book (TTM)
2.06
Price to free cash flow (TTM)
13.622
Free cash flow yield (TTM)
7.34%
Free cash flow per share (TTM)
0.882
Growth
Revenue change (TTM)
-1.36%
Earnings per share change (TTM)
-502.13%
3-year revenue growth (CAGR)
-1.30%
3-year earnings per share growth (CAGR)
73.80%
What the Analysts think about Varex
Analyst ratings (Buy, Hold, Sell) for Varex stock.
Bulls say / Bears say
Industrial segment revenue rose 1% year-over-year to $60.9 million in Q3 FY25, underscoring the company’s diversification beyond its core medical business. (Nasdaq)
Non-GAAP gross margin expanded to 34% in Q3 FY25 from 32% a year earlier, driven by higher volumes and a favorable product mix. (Nasdaq)
On June 2, 2025, Varex paid down $200 million of its convertible notes, significantly reducing debt and simplifying its capital structure. (Nasdaq)
Total revenues for Q3 FY25 fell 3% year-over-year to $203 million, with medical segment revenue down 4%, indicating persistent headwinds in the medical imaging market. (Nasdaq)
The company reported a GAAP net loss of $2.15 per diluted share in Q3 FY25, reflecting significant one-time charges and goodwill impairments that weighed on overall profitability. (Nasdaq)
Guidance for Q4 FY25 non-GAAP EPS of $0.10 to $0.30 suggests constrained earnings growth in the near term amid only modest revenue improvement expectations. (Nasdaq)
Data summarised monthly by Lightyear AI. Last updated on 7 Nov 2025.
Varex Financial Performance
Revenues and expenses
Varex Earnings Performance
Company profitability
Varex News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Varex stock?
Varex (VREX) has a market cap of $499M as of November 14, 2025.
What is the P/E ratio for Varex stock?
The price to earnings (P/E) ratio for Varex (VREX) stock is 0 as of November 14, 2025.
Does Varex stock pay dividends?
No, Varex (VREX) stock does not pay dividends to its shareholders as of November 14, 2025.
When is the next Varex dividend payment date?
Varex (VREX) stock does not pay dividends to its shareholders.
What is the beta indicator for Varex?
Varex (VREX) has a beta rating of 0.68. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.